Xianggen Wu Selected Research

balofloxacin (Q 35)

8/2014

In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianggen Wu Research Topics

Disease

5	Keratitis 02/2021 - 08/2012
3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022 - 12/2021
3	Burns 12/2021 - 03/2020
2	Eye Infections 01/2021 - 10/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2013
2	Wounds and Injuries (Trauma) 01/2021 - 07/2020
2	Infections 08/2012 - 04/2012
2	Endophthalmitis (Ophthalmia) 04/2012 - 10/2011
2	Inflammation (Inflammations) 04/2012 - 10/2011
1	Reperfusion Injury 01/2022
1	Pancreatitis 01/2022
1	Ischemia 01/2022
1	Cicatrix (Scar) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Bacterial Infections (Bacterial Infection) 02/2021
1	Glaucoma 01/2021
1	Neoplasms (Cancer) 01/2020
1	Eye Diseases (Eye Disease) 12/2019
1	Corneal Injuries 12/2019
1	Ulcerative Colitis 01/2019
1	Blindness (Hysterical Blindness) 04/2013
1	Edema (Dropsy) 12/2012

Drug/Important Bio-Agent (IBA)

9	Ophthalmic Solutions (Eye Drops)IBA 12/2021 - 04/2012
5	MicellesIBA 01/2022 - 12/2019
4	SolutionsIBA 12/2021 - 04/2012
3	AlkaliesIBA 12/2021 - 03/2020
3	Glycyrrhizic Acid (Glycyrrhizin)IBA 12/2021 - 01/2021
3	Levofloxacin (Levaquin)FDA Link 04/2020 - 04/2012
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2013
2	SaltsIBA 12/2021 - 04/2012
2	HMGB1 Protein (HMG1)IBA 12/2021 - 01/2021
2	Therapeutic UsesIBA 07/2020 - 10/2011
2	Gemifloxacin (Factive)FDA Link 08/2012 - 04/2012
2	FluoroquinolonesIBA 08/2012 - 04/2012
1	pterostilbeneIBA 01/2022
1	Netrin-1IBA 01/2022
1	InflammasomesIBA 01/2022
1	PolymersIBA 01/2022
1	empagliflozinIBA 01/2022
1	CaprolactamIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	polyvinyl acetateIBA 01/2022
1	MelatoninIBA 01/2022
1	PolyvinylsIBA 01/2022
1	rebamipideIBA 12/2021
1	naringeninIBA 12/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2021
1	Rose BengalIBA 12/2021
1	xanthan gum (xanthan)FDA LinkGeneric 02/2021
1	Linezolid (Zyvox)FDA Link 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021
1	hesperetinIBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Nimodipine (Modus)FDA LinkGeneric 01/2021
1	rebaudioside AIBA 01/2021
1	SuspensionsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	CytokinesIBA 07/2020
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2020
1	GelsIBA 04/2020
1	Liposomes (Liposome)IBA 01/2020
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 01/2020
1	polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymerIBA 12/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	balofloxacin (Q 35)IBA 08/2014
1	Multidrug Resistance-Associated ProteinsIBA 11/2013
1	major vault proteinIBA 11/2013
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2013
1	3-hydroxycholest-7-ene-14-carbaldehydeIBA 11/2013
1	Retinal Pigments (Pigments, Visual)IBA 11/2013
1	pazufloxacinIBA 04/2012
1	Moxifloxacin (Avelox)FDA Link 04/2012
1	glycolic acid (glycolate)IBA 10/2011
1	Voriconazole (Vfend)FDA LinkGeneric 10/2011
1	Pharmaceutical PreparationsIBA 10/2011

Therapy/Procedure

2	Topical Administration 12/2021 - 12/2021
2	Oral Administration 07/2020 - 01/2019
1	Transplantation 01/2022
1	Therapeutics 01/2020
1	Ophthalmic Administration 12/2019
1	Corneal Transplantation (Keratoplasty) 04/2013
1	Slit Lamp 12/2012
1	Intravitreal Injections 10/2011